Shopping Cart
- Remove All
- Your shopping cart is currently empty
Iniparib (BSI-201) (BSI-201) , a PARP1 inhibitor, exhibits potency in triple-negative breast Y (TNBC).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $46 | In Stock | |
10 mg | $70 | In Stock | |
25 mg | $128 | In Stock | |
50 mg | $241 | In Stock | |
100 mg | $378 | In Stock | |
200 mg | $600 | In Stock | |
500 mg | $959 | In Stock | |
1 mL x 10 mM (in DMSO) | $50 | In Stock |
Description | Iniparib (BSI-201) (BSI-201) , a PARP1 inhibitor, exhibits potency in triple-negative breast Y (TNBC). |
In vivo | In 855-2 cells, the combination of BSI-201 (120 μM) and buthionine sulfoximine induced cell death up to 95%, which was similar to the effect on other human tumor cells. In E-ras 20 cells, BSI-201 inhibited cell growth, and its effect was enhanced 20-fold when combined with buthionine sulfoximine. BSI-201 (100 μM) inhibited the repair of ionizing radiation-induced single-strand breaks (SSBs) in human lymphocyte cell lines. |
Cell Research | Cells are exposed to various concentrations of BSI-201 for 5, and 9 days in the presence or absence of buthionine sulfoxamide (BSO). After treatment, cell proliferation is measured by CellTiter-Glo assay.(Only for Reference) |
Alias | NSC-746045, IND-71677, BSI-201 |
Molecular Weight | 292.03 |
Formula | C7H5IN2O3 |
Cas No. | 160003-66-7 |
Smiles | N(=O)(=O)C1=CC(C(N)=O)=CC=C1I |
Relative Density. | 2.055 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||||||||||||
Solubility Information | Ethanol: 14.6 mg/mL (50 mM) DMSO: 85 mg/mL (291.07 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.